Respiratory Distress Syndrome in Premature Infant
📧 Sign up to get email alerts when something new happens for Respiratory Distress Syndrome in Premature Infant.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Update: Respiratory Effect of the LISA Method With Sedation by Propofol Versus Absence of Sedation. [Phase 3]
Phase 3 clinical trial comparing respiratory outcomes of the LISA method with propofol sedation versus no sedation in premature infants with…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Effect of Implementing Evidence Based Practices on Prevention of Associated Nasal Pressure Injuries Among Preterm Neonates With Non-Invasive Respiratory Support [NA]
This clinical trial update examines whether implementing evidence-based practices can prevent nasal pressure injuries in preterm neonates re…
-
CLINICAL_TRIALS research · 2024-06-03Clinical Trial Update: Risk Factors of Meconium Obstruction and Respiratory Distress Syndrome in Preterm Infants
A completed clinical trial update examining risk factors for meconium obstruction of prematurity and respiratory distress syndrome in preter…
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: Novel Low Cost Bubble CPAP as an Alternative Respiratory Support in Low Resource Setting [Phase 2]
Phase 2 trial update evaluating a novel low-cost bubble CPAP as an alternative respiratory support in premature infants with respiratory dis…
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia. [Phase 3]
Phase 3 trial evaluating intratracheal budesonide with surfactant to prevent bronchopulmonary dysplasia in premature infants; status current…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome [Phase 2]
Phase 2 trial assessing recombinant human Clara Cell 10 Protein (rhCC10) for respiratory distress syndrome in premature neonates; results ha…